Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Molecular Pharmacology|November 30, 2006
Inhibition of the c-Jun N-terminal kinase-mediated mitochondrial cell death pathway restores auditory function in sound-exposed animalsJing Wang, Jérôme Ruel, Sabine Ladrech, et al.Plos One|July 2, 2014
Regulation of the JNK3 signaling pathway during islet isolation: JNK3 and c-fos as new markers of islet quality for transplantationSaida Abdelli, Klearchos K Papas, Kate R Mueller, et al.American Journal of Physiology. Heart and Circulatory Physiology|December 13, 2006
A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivoGiuseppina Milano, Sandrine Morel, Christophe Bonny, et al.Stroke|June 5, 2004
D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemiaLorenz Hirt, Jérôme Badaut, Jonathan Thevenet, et al.Investigative Ophthalmology & Visual Science|June 26, 2003
Induction of apoptosis in human corneal and HeLa cells by mutated BIGH3Sabine Morand, Valérie Buchillier, Fabienne Maurer, et al.Clinical & Experimental Ophthalmology|January 13, 2006
D-TAT transporter as an ocular peptide delivery systemDaniel F Schorderet, Violaine d'Allèves Manzi, Kriss Canola, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 12, 2008
Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinasesKathrin Maedler, Fabienne T Schulthess, Christelle Bielman, et al.Journal of Gastroenterology and Hepatology|March 10, 2022
Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's diseaseWalter Reinisch, Xavier Hébuterne, Anthony Buisson, et al.Nature Medicine|August 26, 2003
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemiaTiziana Borsello, Peter G H Clarke, Lorenz Hirt, et al.Journal of Diabetes Research|July 16, 2014
JNK3 is required for the cytoprotective effect of exendin 4Hélène Ezanno, Valérie Pawlowski, Saida Abdelli, et al.Pageof 5